Clinical Trial Update: A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension [Phase 3]

View source ↗

Summary

A long-term safety study evaluating the combination of aliskiren, amlodipine, and hydrochlorothiazide in participants with essential hypertension (Phase 3) has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• aliskiren/amlodipine/hydrochlorothiazide

Snippet

Sponsor: Novartis | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2021-06-07